Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-011047)

Filing Details

Accession Number:: 0001209191-23-011047
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-21 12:38:45
Reporting Period:: 2023-02-16

Accepted Time:: 2023-02-21 12:38:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1877741	Ghazi Kashmolah	1412 62Nd Street Emeryville CA 94608	Ex Vp & Chief Quality Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-02-16	5,028	$0.27	134,075	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Unitsgranted on September 30,2021 for 197,240 shares.